Leon Cooperman Gets a Boost Off of NXP Semiconductors Surge

NXP Semiconductors

NXP Semiconductors NV (NASDAQ:NXPI), Voltari Corp. (NASDAQ:VLTC) and Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) kicked off the first week of March with big gains. Pacira Pharmaceuticals Inc. (NASDAQ:PCRX), Seventy Seven Energy Inc. (NYSE:SSE) and Navient Corporation (NASDAQ:NAVI) took dives.

Sign up for our free newsletter

NXP Semiconductors Rallies on Freescale Acquisition

Top value fund managers are ready for the small cap bear market to be done

InvestorsDuring the bull market, small caps haven't been performing well, but some believe that could be about to change. Breach Inlet Founder and Portfolio Manager Chris Colvin and Gradient Investments President Michael Binger both expect small caps to take off. Q1 2020 hedge fund letters, conferences and more However, not everyone is convinced. BTIG strategist Read More

NXP Semiconductors NV rallied +17.27% this Monday in the wake of an announcement that it will acquire Freescale for $11.8 billion. With 3.45% of his publicly equity portfolio allocated to NXPI as of Q4, Leon Cooperman will get a boost off of the news.


Voltari Corp. surged +12.94% today, putting its year-to-date gain at +25.77%. Billionaire Carl Icahn owns 14.51% of the digital marketing and advertising solutions company.

Cyclacel Pharmaceuticals climbed +12.67%, ending the day at $1.69. The billionaire with a stake in this one: Wilbur Ross.

Parica Pharmaceuticals Tumbles on FDA Rejection

Pacira Pharmaceuticals tumbled -19.58% in the wake of news that the FDA has rejected its application to expand the use of its post-surgery pain drug, Exparel. George Soros is taking a hit on this one.

Seventy Seven Energy plunged -9.58% this Monday, putting its YTD loss at -19.78% and its performance since going public at -82.39%. Carl Icahn wound up with a stake in the firm after it spun off of Chesapeake Energy and maintained his position in Q4.

Navient Corporation dipped -8.83% after equities researchers at Compass Point downgraded the stock from a buy to a neutral rating. Leon Cooperman has a position in the firm.

Screen Shot 2015-02-23 at 3.00.26 PM